Utama › Kanser Salur Bilier
Kajian klinikal Kanser Salur Bilier sedang mengambil peserta di AS
40 kajian untuk Kanser Salur Bilier sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX18 kajian
- Los Angeles, CA11 kajian
- Boston, MA11 kajian
- New York City, NY10 kajian
- Nashville, TN9 kajian
- San Antonio, TX8 kajian
- Baltimore, MD8 kajian
- Washington, DC7 kajian
- Pittsburgh, PA7 kajian
- Arlington, VA7 kajian
- Dallas, TX6 kajian
- Cleveland, OH6 kajian
- Columbus, OH6 kajian
- Baldwin Park, CA6 kajian
- Madison, WI6 kajian
- Philadelphia, PA6 kajian
- Detroit, MI5 kajian
- Louisville, KY5 kajian
- Tampa, FL5 kajian
- Miami, FL5 kajian
- Seattle, WA4 kajian
- Orange, CA4 kajian
- Queens, NY4 kajian
- Aurora, CO4 kajian
- Orlando, FL4 kajian
- Buffalo, NY3 kajian
- Edison, NJ3 kajian
- Santa Monica, CA3 kajian
- St. Louis, MO3 kajian
- Salt Lake City, UT3 kajian
- San Diego, CA3 kajian
- Grand Rapids, MI3 kajian
- Chicago, IL3 kajian
- Tucson, AZ3 kajian
- Providence, RI3 kajian
- Denver, CO3 kajian
- Portland, OR3 kajian
- Birmingham, AL3 kajian
Mengikut negeri
- Alabama3 kajian
- Arizona4 kajian
- California20 kajian
- Colorado7 kajian
- Connecticut3 kajian
- Florida14 kajian
- Georgia4 kajian
- Illinois5 kajian
- Kentucky6 kajian
- Maryland11 kajian
- Massachusetts11 kajian
- Michigan9 kajian
- Minnesota5 kajian
- Missouri4 kajian
- New Jersey5 kajian
- New York15 kajian
- Ohio10 kajian
- Oregon3 kajian
- Pennsylvania10 kajian
- Rhode Island3 kajian
- Tennessee10 kajian
- Texas23 kajian
- Utah4 kajian
- Virginia9 kajian
- Washington5 kajian
- Wilayah Columbia4 kajian
- Wisconsin6 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01950572A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06219941A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07265674Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05482893A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06428409Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Mengambil pesertaFasa 2
Umur 18 hingga 130 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05489211Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Mengambil pesertaFasa 2
Umur 19 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07146646Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06282575SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07812805Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06548412AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Mengambil pesertaFasa 1/2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06084481Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 99 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05517811A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06774963Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 hingga 99 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT06467357A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06330064D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT06622057A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07458347Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.